Retrospective studies that evaluated long-term outcomes in BRCA1/2 carriers have found no significant difference in RFS, breast cancer-specific survival (BCSS), or OS, between BCS and mastectomy; however, an increased risk of local recurrence was reported for BCS (78–81). Here, BRCA1 is linked to breast carcinoma.